BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Business

  H. D. Smith Announces Passing Of Founder And CEO Emeritus, Henry Dale Smith Sr.

  September 21, 2015

   · 

  2 min read
• Drug Development

  ERS 2015: Landmark Year For Boehringer Ingelheim’s Respiratory Portfolio - New Data For COPD, IPF And Asthma Treatments

  September 21, 2015

   · 

  5 min read
• BioMidwest

  Cogentix Medical Enters Into $7.0 Million Line Of Credit With Venture Bank

  September 21, 2015

   · 

  4 min read
• Drug Development

  Sangamo BioSciences Reports Updated Clinical Data From ZFP Therapeutic Program For HIV/AIDS At The 2015 Interscience Conference Of Antimicrobial Agents And Chemotherapy

  September 21, 2015

   · 

  7 min read
• Drug Development

  RegeneRx Biopharmaceuticals, Inc. Announces First Patient Enrolled In Phase 3 U.S. Neurotrophic Keratopathy (NK) Clinical Trial With RGN-259

  September 21, 2015

   · 

  6 min read
• Deals

  Q BioMed Inc. Is Pleased To Announce A Letter-Of-Intent To Exclusively In-License And Ultimately Acquire The Assets Of Mannin Research Inc.

  September 21, 2015

   · 

  6 min read
• Biotech Beach

  Results from Second Large-Scale Clinical Trial For TrovaGene, Inc.'s Urine-based HPV Test Released

  September 21, 2015

   · 

  4 min read
• Drug Development

  Veloxis Pharmaceuticals A/S Announces Publication Of Phase III-B STRATO Study Of Envarsus XR Demonstrating Reduction In Hand Tremors Compared To Twice-Daily Tacrolimus In Kidney Transplant Patients

  September 21, 2015

   · 

  5 min read
• CPhA Welcomes NDP Commitment To Improve Prescription Drug Access And Affordability For Canadians

  September 21, 2015

   · 

  2 min read
• Pharm Country

  Taro Pharmaceutical Industries Ltd.’s Keveyis (Dichlorphenamide) 50 Mg Tablets Now Available For The Treatment Of Primary Hyperkalemic And Hypokalemic Periodic Paralysis

  September 21, 2015

   · 

  6 min read